Vitamin C metabolites, independent of smoking status, significantly enhance leukocyte, but not plasma ascorbate concentrations
- First Online:
The objective of this study was to test the effects of acute doses of vitamin C alone, calcium ascorbate with vitamin C metabolites, and placebo, on total plasma and leukocyte vitamin C concentrations over 24 hours.
A double-blind, placebo-controlled, four-way crossover study was performed consisting of four separate phases lasting 24 hours each and utilizing one of four oral 1000-mg preparations within each phase (one of vitamin C alone, two separate vitamin C formulations of calcium ascorbate with vitamin C metabolites, and placebo). There was a 7-day washout between phases, and blood draws at seven time points within each phase of the study for a total of 28 serologic measurements per subject and 420 total measurements for the entire clinical trial. Vitamin C concentration in plasma and leukocytes were measured by high-performance liquid chromatography at baseline and at six sequential time periods over 24 hours.
Fifteen healthy males were enrolled, aged 18–39 years; nine were had never smoked and six were chronic smokers. No significant difference in plasma vitamin C levels was observed when comparing the different preparations. However, at 24 hours, calcium ascorbate with metabolites resulted in significantly higher concentrations of vitamin C in leukocytes (P<0.0001) compared with vitamin C alone. These results were similar for both metabolite formulations, and independent of smoking status.
Regardless of smoking status, vitamin C metabolites may enhance leukocyte utilization of vitamin C itself, despite no consistent difference in plasma levels among the different preparations. A larger clinical investigation is warranted to confirm these preliminary findings, and to determine the clinical relevance of this impact on overall immune function.
Keywordsascorbic acid calcium threonate immune function vitamin C metabolites white blood cells
Unable to display preview. Download preview PDF.
- 5.Christen WG, Gaziano JM, Hennekens CH. Design of Physicians’ Health Study II—a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol. 2000;10:125–134.PubMedCrossRefGoogle Scholar
- 10.Anderson, RA. Vitamin C. In: Hughes DA, Darlington LG, Bendich A, editors. Diet and Human Immune Function. Totowa, NJ: Humana Press, Inc.; 2004:133–148.Google Scholar
- 13.Michos C, Kiortsis DN, Evangelou A, Karkabounas S. Antioxidant protection during the menstrual cycle: the effects of estradiol on ascorbic-dehydroascorbic acid plasma levels and total antioxidant plasma status in eumenorrhoic women during the menstrual cycle. Acta Obstet Gynecol Scand. 2006;85:960–965.PubMedCrossRefGoogle Scholar
- 30.Selby SM. Standard Mathematical Tables. 20th edition. Cleveland, Ohio: CRC Press; 1972.Google Scholar
- 31.Douglas RM, Hemilä H, Chalker E, Treacy B. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2007;(3):CD000980.Google Scholar
- 32.Moyad MA, Combs MA. Vitamin C dietary supplements: an objective review of the clinical evidence. Part I. Sem Prev Alt Med. 2007;3:25–35.Google Scholar
- 33.Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: ARED Report No. 8. Arch Ophthalmol. 2001;119:1417–1436.Google Scholar
- 36.Stoltzfus RJ. Iron deficiency: global prevalence and consequences. Food Nutr Bull. 2003;24(suppl. 4):99–103.Google Scholar